Lumateperone

CAPLYTA

Atypical Antipsychotic

NADAC/unit $57.3299

No Shortage Tier 1: 53.8% PA Req: 100.3%

Lumateperone treats schizophrenia, bipolar disorder, and related conditions by modulating dopamine and serotonin receptors.

vs. brand CAPLYTA: Generic saves up to -473% per unit

Covered Lives

Generic Manufacturers

INTRA-CELLULAR THERAPIES INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Lumateperone drfinder.aiFind doctors who prescribe Lumateperone rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Lumateperone

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.